Risk of Developing Alzheimer’s Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up

BACKGROUND: There is no any large randomized clinical trial of antihypertensive drug treatment with 18-year passive follow-up to examine the risk of Alzheimer’s Disease (AD) or Related Dementias (ADRD). METHODS: Post-trial passive follow-up study of Antihypertensive and Lipid-Lowering Treatment to P...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xianglin L., Simpson, Lara M., Osani, Mikala C., Yama, Jose-Miguel, Davis, Barry R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095428/
https://www.ncbi.nlm.nih.gov/pubmed/35571234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095428/
https://www.ncbi.nlm.nih.gov/pubmed/35571234

Ejemplares similares